Poor quality of medicines affects all countries but in particular vulnerable populations in low- and middle-income countries. There is increasing interest in poor quality medical products, their epidemiology, detection, and impact and how to intervene to reduce their frequency. The number of research groups and international organizations working in this field has seen a modest increase over the past decade, accompanied by the growing engagement of medicines regulatory agencies and the pharmaceutical industry.
In spite of some progress there are many remaining challenges, from legal issues to the lack of funding, and more evidence is needed to help inform policy and build research capacity. This course will address the need to build capacity in quality assurance of medical products, and stimulate more research and action in this neglected field. Hosted at the London School of Hygiene & Tropical Medicine in 2015 and 2016, this short course on Quality of Medical Products and Public Health will be hosted by Boston University School of Public Health in July 2017.
Participants will learn to understand and discuss issues related to:
- medicine quality definitions;
- the epidemiology of poor quality medicines and the data gaps that need to be filled;
- the basics of medicine regulation, GMP and laws as they relate to medicines quality;
- the basics of chemical & packaging analysis and rapid tests;
- the steps needed to improve the global supply of quality assured medicines and how advocate for them.
International Teaching Faculty
- Dr. Céline Caillet
Infectious Diseases Data Observatory (IDDO), University of Oxford, UK
- Mr. Mick Deats
- Prof. Marya Lieberman
University of Notre Dame
- Dr. Raffaella Ravinetto
Institute of Tropical Medicine, Belgium
- Mr. Tim Muntinga
Oxford University, UK
- Mr. Jude Nwokike
United States Pharmacopeial Convention
- Prof. Muhammad Zaman
- Nicola Ranieri
US FDA Forensic Chemistry Center
- Dr. David Gaul
Georgia Institute of Technology
The course is aimed at professionals who work in regulatory bodies; health policy and funding agencies; international health organizations; academia and pharmaceutical industries and who are involved and/or interested in quality of medical products (e.g. medicines, diagnostics, vaccines).
Monday, July 10 – Friday, July 14, 2017
Special Program Notes
Participants from low and middle income countries are provided with a 25 percent discount on the cost of the program. Please indicate this in the discount section when registering.
The application for this program is closed.